Comorbidity and Health Management: Tuesday Night Rheumatology
Comorbidity and Health Management: Tuesday Night Rheumatology tammytilley@gm… Fri, 12/26/2025 – 12:38 General Rheumatology Drug Safety Education/ACR/EULAR Rheumatoid Arthritis NP/PA […]
RheumNow
RheumNow
Best of 2025: Glossary for Giant Cell Arteritis
Best of 2025: Glossary for Giant Cell Arteritis jjcush@gmail.com Fri, 12/26/2025 – 08:15
RheumNow
Best of 2025: Glucocorticoids in SLE: how to start, how to follow, how to stop
Best of 2025: Glucocorticoids in SLE: how to start, how to follow, how to stop r.irastorza@ou… Fri, 12/26/2025 – 08:00
RheumNow
EULAR Classification criteria for hemachromatosis, presented by Prof. Kiely shows clinical pearls in diagnosis – Hook os
EULAR Classification criteria for hemachromatosis, presented by Prof. Kiely shows clinical pearls in diagnosis – Hook os https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
RheumNow
APP Pearls “Never stop learning—rheumatology is full of surprises” – Kayla Carlucci, FNP-BC
APP Pearls “Never stop learning—rheumatology is full of surprises” – Kayla Carlucci, FNP-BC https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 12/24/2025 – 16:00 RheumNow
RheumNow
BREAKING NEWS: How many patients with RA achieve and maintain remission with a JAKi? Find out in the RheumNow poster hal
BREAKING NEWS: How many patients with RA achieve and maintain remission with a JAKi? Find out in the RheumNow poster
RheumNow
Nerandomilast FDA Approved for Progressive Pulmonary Fibrosis The FDA has approved nerandomilast (Jascayd), a PDE4b in
Nerandomilast FDA Approved for Progressive Pulmonary Fibrosis The FDA has approved nerandomilast (Jascayd), a PDE4b in https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 12/24/2025
RheumNow
Three Things to Know About Hiring, Onboarding, and Training APPs As the utilization of APPs (nurse practitioners and p
Three Things to Know About Hiring, Onboarding, and Training APPs As the utilization of APPs (nurse practitioners and p https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Best of 2025: Distinguishing Septic and Gouty Arthritis
Best of 2025: Distinguishing Septic and Gouty Arthritis jjcush@gmail.com Wed, 12/24/2025 – 08:15
RheumNow
Best of 2025: Dermatomyositis Reviewed
Best of 2025: Dermatomyositis Reviewed jjcush@gmail.com Wed, 12/24/2025 – 08:00
Lupus Guidelines 2025
Lupus Guidelines 2025 tammytilley@gm… Tue, 12/23/2025 – 21:57 Lupus Drug Safety Education/ACR/EULAR General Rheumatology NP/PA Coverage Monica Richey, ANP, New
RheumNow
Telling You Where to Go (12.19.2025) Dr. Jack Cush reviews the news and journal articles from the past week on RheumNo
Telling You Where to Go (12.19.2025) Dr. Jack Cush reviews the news and journal articles from the past week on
RheumNow
Evaluation of Rheumatic Complaints https://t.co/3p3dtlUKpQ https://t.co/XseCMhvpnN
Evaluation of Rheumatic Complaints https://t.co/3p3dtlUKpQ https://t.co/XseCMhvpnN https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/23/2025 – 18:30 RheumNow Dr. John Cush Evaluation of Rheumatic Complaints
RheumNow
Comorbidity and Health Management https://t.co/2jDcBmP4zt
Comorbidity and Health Management https://t.co/2jDcBmP4zt https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/23/2025 – 19:00 RheumNow Dr. John Cush Comorbidity and Health Management https://t.co/2jDcBmP4zt
RheumNow
APP Controversies and Misconceptions In this Tuesday Night Rheumatology, panelists discuss a range of topics, includin
APP Controversies and Misconceptions In this Tuesday Night Rheumatology, panelists discuss a range of topics, includin https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/23/2025
RheumNow
APP Pearls “You must assess sleep and mood- without this, even if you control all inflammation, you will not control p
APP Pearls “You must assess sleep and mood- without this, even if you control all inflammation, you will not control
RheumNow
Tricks of the Trade – Clinic Advice from APPs December 2025 is focused on advanced practice providers, their impact,
Tricks of the Trade – Clinic Advice from APPs December 2025 is focused on advanced practice providers, their impact, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Best of 2025: Vitamin D for Prevention of Disease
Best of 2025: Vitamin D for Prevention of Disease jjcush@gmail.com Tue, 12/23/2025 – 08:15
RheumNow
Best of 2025: Antifibrotics – A New Class of Therapies in Rheumatology?
Best of 2025: Antifibrotics – A New Class of Therapies in Rheumatology? shervin.assass… Tue, 12/23/2025 – 08:00
RheumNow
Hidden in Plain Sight: IBD As a PA with six years of experience in rheumatology and a background in gastroenterology,
Hidden in Plain Sight: IBD As a PA with six years of experience in rheumatology and a background in gastroenterology,
RheumNow
Disease Activity Criteria for Adult-Onset Still’s Disease: EULAR Points to Consider EULAR has published a “points to c
Disease Activity Criteria for Adult-Onset Still’s Disease: EULAR Points to Consider EULAR has published a “points to c https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Evaluation of Rheumatic Complaints https://t.co/9BSY80fsV2 https://t.co/hzRVha4ut0
Evaluation of Rheumatic Complaints https://t.co/9BSY80fsV2 https://t.co/hzRVha4ut0 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 12/22/2025 – 16:00 RheumNow Dr. John Cush Evaluation of Rheumatic Complaints
RheumNow
NPs and PAs: Opportunities Outside of the Exam Room Ben Smith, PA-C, Thomasville, GA, discusses scholarly and leadersh
NPs and PAs: Opportunities Outside of the Exam Room Ben Smith, PA-C, Thomasville, GA, discusses scholarly and leadersh https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
GC dose and tapering may influence serious infection risk in patients with GCA. Discover the key safety outcomes observe
GC dose and tapering may influence serious infection risk in patients with GCA. Discover the key safety outcomes observe https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Best of 2025: Methotrexate intolerance in rheumatoid arthritis
Best of 2025: Methotrexate intolerance in rheumatoid arthritis jjcush@gmail.com Mon, 12/22/2025 – 09:30
RheumNow
“Absence of proof of efficacy does not equal proof of absence of efficacy” – Arthur Kavanaugh, MD
“Absence of proof of efficacy does not equal proof of absence of efficacy” – Arthur Kavanaugh, MD https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun,
RheumNow
Evaluation of Rheumatic Complaints https://t.co/cdizOgFqYf https://t.co/YHLAllxpO4
Evaluation of Rheumatic Complaints https://t.co/cdizOgFqYf https://t.co/YHLAllxpO4 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sat, 12/20/2025 – 16:00 RheumNow Dr. John Cush Evaluation of Rheumatic Complaints